News
Growing Pipeline of ADC Candidates for Various Cancer Indications is Driving the IndustryDublin, April 25, 2025 (GLOBE NEWSWIRE) -- The An ...
GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...
GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ATLANTA, GA - ...
Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...
Safi to bulk manufacture Children's Hospital of Philadelphia's iPSC-derived RBCs with rare antigen profiles as diagnostic tools for alloim ...
Discover comprehensive insights into approved therapeutics and research developments targeting Prostate-Specific Membrane Antigen (PSMA). This product provides detailed competitor analysis, R&D stages ...
Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...
3d
Pharmaceutical Technology on MSNDAAN Biotherapeutics and GC Cell agree on CAR-T, CAR-NK therapiesSouth Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...
Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s ...
G protein-coupled receptors (GPCRs) are involved in many diseases, yet raising therapeutic antibodies against them is notoriously difficult because the transmembrane receptors contain only short ...
EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as 'Tregitopes' on antibody maturation during immune response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results